Volume of surgical resection by liver focal lesions

Zhao A.V.; Kovalenko Yu.A.; Chugunov A.O.; Novruzbekov M.S.

doi:https://doi.org/

Zhao A.V.

FGBU "Institut khirurgii im. A.V. Vishnevskogo" Minzdrava Rossii, Moskva

ORCID: 0000-0002-2146-5136

Kovalenko Yu.A.

Federal state budgetary institution «A.A. Vishnevsky Institute of Surgery», Russian Ministry of Health (director: B.A. Kubyshkin, member of Russian Academy of Sciences]

SPIN RSCI: 2809-4942
Scopus AuthorID: 57192228587
ORCID: 0000-0001-9879-6403

Chugunov A.O.

Otdelenie transplantatsii pecheni Nauchno-issledovatel'skogo instituta skoroĭ pomoshchi im. N.V. Sklifosovskogo, Moskva

Novruzbekov M.S.

Otdelenie transplantatsii pecheni Nauchno-issledovatel'skogo instituta skoroĭ pomoshchi im. N.V. Sklifosovskogo, Moskva

ORCID: 0000-0002-6362-7914

Volume of surgical resection by liver focal lesions

Authors:

Zhao A.V., Kovalenko Yu.A., Chugunov A.O., Novruzbekov M.S.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2010;(5): 15‑20

Read: 1365 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Zhao AV, Kovalenko YuA, Chugunov AO, Novruzbekov MS. Volume of surgical resection by liver focal lesions. Pirogov Russian Journal of Surgery. 2010;(5):15‑20. (In Russ.)

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

The results of surgical interventions for colon cancer with spread to the organs of the pancreatoduodenal zone. Pirogov Russian Journal of Surgery. 2026;(3):26-32

Features of neoadjuvant antitumor chemotherapy for hereditary breast cancer, BRCA-associated and without identified mutations. P.A. Herzen Journal of Oncology. 2026;(1):11-17

The role of the tumor microenvironment and BAP1 protein expression in the prognosis of uveal melanoma. Russian Annals of Ophthalmology. 2026;(2):21-28

Abstract:

Results of surgical treatment of 109 patients with focal lesions of the liver were analyzed. Volume resection by malignant and benign liver lesions was defined, depending on size, localization, number of foci and functional liver reserve. Postoperative lethality of patients with colorecatal cancer metastases was 4.3%. Method of surgical treatment depended directly on the tumor stage. Overall 5-year survival by stage IVA hepatocellular cancer was 48%, 3.5-year survival was 62%. Overall and desease-free survival by colorecatal cancer metastases was 35.1 and 22.4%, respectively.

Keywords:

volume of resection

method of resection

liver tumors

survival

Authors:

Zhao A.V.

FGBU "Institut khirurgii im. A.V. Vishnevskogo" Minzdrava Rossii, Moskva

ORCID: 0000-0002-2146-5136

Kovalenko Yu.A.

Federal state budgetary institution «A.A. Vishnevsky Institute of Surgery», Russian Ministry of Health (director: B.A. Kubyshkin, member of Russian Academy of Sciences]

SPIN RSCI: 2809-4942
Scopus AuthorID: 57192228587
ORCID: 0000-0001-9879-6403

Chugunov A.O.

Otdelenie transplantatsii pecheni Nauchno-issledovatel'skogo instituta skoroĭ pomoshchi im. N.V. Sklifosovskogo, Moskva

Novruzbekov M.S.

Otdelenie transplantatsii pecheni Nauchno-issledovatel'skogo instituta skoroĭ pomoshchi im. N.V. Sklifosovskogo, Moskva

ORCID: 0000-0002-6362-7914

Close metadata

References:

Vishnevskii V.A., Efanov M.G., Ikramov R.Z. i dr. Otdalennye rezul'taty obshirnykh i segmentarnykh rezektsii pecheni po povodu gepatotsellyulyarnogo raka. Annaly khir gepatol 2008; 13: 3: 89.
Vishnevskii V.A., Kubyshkin V.A., Chzhao A.V., Ikramov R.Z. Operatsii na pecheni. M 2003; 156.
Gritsaenko A.I. Diagnostika i khirurgicheskoe lechenie gemangiom pecheni: Avtoref. dis. … kand. med. nauk. Ufa 2006; 21.
Patyutko Yu.I. Khirurgicheskoe lechenie zlokachestvennykh opukholei pecheni. M: Prakticheskaya meditsina 2005; 312.
Patyutko Yu.I., Lazarevich N.L., Sagaidak I.V. i dr. Otdalennye rezul'taty khirurgicheskogo lecheniya gepatotsellyulyarnogo raka, prognosticheskie faktory. Annaly khir gepatol 2008; 13: 3: 98.
Pikunov M.Yu., Vishnevskii A.A., Vishnevskii V.A. Ionkin D.A. Metastazy kolorektal'nogo raka v legkie i pechen' - novye vozmozhnosti khirurgicheskogo lecheniya. Al'manakh in-ta khir. im. A.V. Vishnevskogo 2008; 3: 3: 29-32.
Polishchuk L.O. Neposredstvennye rezul'taty rezektsii pecheni posle khimioterapii metastazov kolorektal'nogo raka: Dis. … kand. med. nauk. M 2009; 85.
Poluektov V.L., Shutov V.Yu., Podol'skii E.N., Kukhta A.K. Khirurgicheskoe lechenie gepatotsellyulyarnogo raka. Annaly khir gepatol 2008; 13: 3: 99-100.
Polysalov V.N., Granov D.A. Khirurgicheskoe lechenie gemangiom pecheni: zavisimost' khirurgicheskoi taktiki ot formy zabolevaniya. Vopr onkol 2003; 49: 5: 630-635.
Chormanov A.T., Mirzhakypov A.T. Enukleatsiya kak taktika vybora v khirurgicheskom lechenii gemangiom pecheni. Annaly khir gepatol 2008; 13: 3: 295-296.
Abdalla E.K., Vauthey J.N., Ellis L.M. et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825.
Abdalla E.K. Is anatomic resection superior to nonanatomic resection for the treatment of patients with hepatocellular carcinoma? Nature Clinical Practice Gastroenterology and Hepatology 2006; 3: 18-19.
Alberts S.R., Gores G.J., Kim G. et al. Treatment Options for Hepatobiliary and Pancreatic. Mayo Clin Proc 2007; 82: 628-637.
De Haas R.J., Wicherts D.A., Flores E. et al. R1 Resection by Necessity for Colorectal Liver Metastases Is It Still a Contraindication to Surgery? Ann Surg 2008; 248: 626-637.
Ferrero A., Polastri R., Muratore A. et al. Extensive resections for colorectal liver metastases. J Hepatobiliary Pancreat Surg 2004; 11: 92-96.
Grundmann R.T., Hermanek P., Merkel S. et al. Diagnosis and treatment of colorectal liver metastases - worklow. Zentralb Chir 2008; 133: 267-284.
Hasegawa K., Kokudo N., Imamura H. et al. Prognostic Implact of Anatomic Resection for Hepatocellular Carcinoma. Ann Surg 2005; 242: 252-259.
Hazinedaroglu S., Huseyin K., Mehmet Y. Enucleation of Centrally Located Giant Hepatic Hemangioma: Report of Two Cases. Dig Dis Sci 2006; 51: 1213-1217.
Ikai I., Arii S., Kojiro M. et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 2004; 101: 796-802.
Imamura H., Matsuyama Y., Tanaka E. et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38: 200-207.
Iwatsuki S., Esquivel C., Gordon R., Starzl T.E. Liver resection for metastatic colorectal cancer. Surgery 1986; 100: 804-810.
Konopke R., Kersting S., Makowiec F. et al. Resection of Colorectal Liver Metastases: Is a Resection Margin of 3 mm Enough? A Multicenter Analysis of the GAST Study Group. World J Surg 2008; 32: 2047-2056.
Lerner S.M., Hiatt R., Salamandra J. et al. Giant Cavernous Liver Hemangiomas: Effect of Operative Approach on Outcome. Archives of Surgery 2004; 139: 818-821.
Matsumoto K., Yoshimoto J., Sugo H. et al. Relationship between the histological degrees of hepatitis and the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis C. Hepatol Res 2002; 23: 196-201.
Minagawa M., Makuuchi M., Takayama T., Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003; 238: 703-710.
National Comprehensive Cancer Network (NCCN): Clinical Practice Guidelines in Oncology. Hepatobiliary cancers 2008; 2. http://www.nccn.org.
Pawlik T.M., Schulick R.D., Choti M.A. Expanding Criteria for Resectability of Colorectal Liver Metastases. The Oncologist 2008; 13: 51-64.
Pawlik T.M., Scoggins C.R., Zorzi D. Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases. Ann Surg 2005; 241: 715-722.
Portolani N., Coniglio A., Chidoni S. et al. Early and Recurrence After Liver Resection for Hepatocellular Carcinoma Prognostic and Therapeutic Implications. Ann Surg 2006; 243: 229-235.
Teh S.H., Christein J., Donohue J. et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of EndStage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005; 9: 1207-1215.
Tsai H.P., Jeng L.V., Lee W.C., Chen M.F. Clinical Experience of Hepatic Hemangioma Undergoing Hepatic Resection. Digestive Diseases and Sciences 2003; 48: 916-920.
Zakaria S., Donohue J.H., Que F.G. et al. Hepatic Resection for Colorectal Metastases Value for Risk Scoring Systems? Ann Surg 2007; 246: 183-191.